Revisiting the Public Health Implications of the United States – Mexico – Canada Agreement

This commentary re-examines a recent article by Labonté et al on the recent changes to two relevant provisions relating to patent rights in the final version of the United-States-Mexico-Canada Agreement (USMCA). Although the USMCA's final revised version does not add more pharmaceutical patent protection than those that already exist in the three trading partners, the agreement has done little to enhance access to generic medicines and biosimilars

MoreLess

Year of publication:	2020
Authors:	Adekola, Tolulope Anthony
Publisher:	[2020]: [S.l.] : SSRN
Subject:	Mexiko \| Mexico \| Kanada \| Canada \| USA \| United States \| Gesundheitswesen \| Health care system \| Gesundheitspolitik \| Health policy

freely available

Full text |

More access options

Check Google Scholar

In German libraries (KVK)

I need help

Extent:	1 Online-Ressource (2 p)
Type of publication:	Book / Working Paper
Language:	English
Notes:	In: Adekola, T.A. Revisiting the public health implications of the United States–Mexico– Canada agreement. Global Health 16, 50 (2020) Nach Informationen von SSRN wurde die ursprüngliche Fassung des Dokuments June 6, 2020 erstellt
Source:	ECONIS - Online Catalogue of the ZBW

Persistent link: https://www.econbiz.de/10012831987